{
  "first_published_at": "2008-04-01", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON084890", 
  "title": "Advising patients about safe use of herbal medicines - new help available", 
  "tags": "{\"parsed_therapeutic\": [], \"Audience:\": [\"Primary care\", \"Secondary care\"]}", 
  "_document_number": 293, 
  "label": null, 
  "icon": null, 
  "therapeutic_area": [], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Advising patients about safe use of herbal medicines - new help available</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: April 2008</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--Most herbal medicines on the UK market are currently unlicensed products. Standards vary widely, and it is difficult for consumers or healthcare professionals to identify which products are manufactured to acceptable standards with reliable product information. The Herbal Medicines Advisory Committee was set up 2 years ago to advise the MHRA about safety issues related to herbal medicines.<br>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>Most herbal medicines on the UK market are currently unlicensed products. Standards vary widely, and it is difficult for consumers or healthcare professionals to identify which products are manufactured to acceptable standards with reliable product information. <a href=\"/Committees/Medicinesadvisorybodies/HerbalMedicinesAdvisoryCommittee/index.htm\">The Herbal Medicines Advisory Committee</a> was set up 2 years ago to advise the MHRA about safety issues related to herbal medicines.</p><p>The MHRA has previously issued warnings about herbal products that contain the toxic ingredient Aristolochicia species, heavy metals, or potent pharmaceutical substances (eg, fenfluramine).</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Safety case studies:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>Recently, <a href=\"ssLINK/CON084741\" target=\"_blank\">we warned consumers about a herbal body lotion (OSAS)</a> that claimed to contain natural ingredients, but tested positive for betamethasone. The product was brought to our attention by a paediatric dermatologist who was concerned that a parent of a baby he was treating for eczema had started using the product on the infant</li>\r\n\t\t\t\t<li>Reports of suspected adverse drug reactions were linked to an unlicensed herbal product that was marketed for diabetes, which gave dangerous advice to patients to stop taking prescribed medication</li>\r\n\t\t\t</ul></div><p>For further examples of previous safety warnings about herbal medicines that contain potent or toxic ingredients see <a href=\"/Howweregulate/Medicines/Herbalmedicines/HerbalSafetyNews/Currentsafetyissues/index.htm\">Herbal Safety News: Current safety issues</a></p><h2>New regulation to safeguard public health</h2><p>Regulation safeguards will be improved by the recent introduction of the Traditional Herbal Registration (THR) scheme. The first products registered in the UK under this scheme are now coming onto the market. As at March 2008, 11 products have been registered covering a total of ten different herbs. Registered products have been assessed by the MHRA and meet systematic standards of safety, quality, and patient information. Registered products are suitable for use without medical supervision, and indications are based on traditional use rather than proven efficacy. Herbal medicines with a Marketing Authorisation also continue to be available.</p><p>See also&nbsp;<a href=\"ssLINK/CON014134\">Press release: Poor practice in the unlicensed herbal sector - MHRA warns the public to be vigilant</a></p><p>The Herbal Medicines Advisory Committee believes it is important to use the growing availability of regulated products and reliable information to enhance patient safety. Healthcare professionals will be increasingly better placed to advise patients who wish to self-medicate with over-the-counter herbal products on how they can make an informed choice in appropriate situations.</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>How to identify regulated herbal products:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>Herbal medicines with a Traditional Herbal Registration have a THR number on the product label</li>\r\n\t\t\t\t<li>Herbal medicines with a Marketing Authorisation have a PL number on the product label</li>\r\n\t\t\t</ul></div><p>The image below shows part of the label, including THR, for Niteherb (valerian, for temporary relief of sleep disturbances due to symptoms of mild anxiety):</p><p><img border=\"0\" src=\"/idcm2/groups/pl-p/documents/websiteresources/con084893.jpg\"></p><p>The image below shows an extract from the leaflet for Prostasan (saw palmetto, for relief of symptoms of an enlarged prostate), which has a THR:</p><p><img border=\"0\" src=\"/idcm2/groups/pl-p/documents/websiteresources/con084895.jpg\"></p><div class=\"dull_highlight\">\r\n\t\t\t<strong>Sources of information about herbal medicines on the MHRA&rsquo;s website:</strong>\r\n\t\t\t<p>Use the <a href=\"/SearchHelp/A-Zindex/index.htm\">A&ndash;Z index</a> to find:</p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li><strong>Public assessment reports for herbal medicines</strong>:<br>    Covers products with a THR, and contains full information on registered products (including the Summary of Product Characteristics)</li>\r\n\t\t\t\t<li><strong>Herbal information sheets</strong>:<br>    Aimed at consumers; gives non-product-specific information about safe use of individual herbs; a reference collection of these sheets will progressively be prepared, making use of the MHRA&rsquo;s assessment of THR applications</li>\r\n\t\t\t\t<li><strong>Advice to consumers&mdash;safe use of herbal medicines</strong>:<br>    Gives general advice, including avoidance of low-grade unlicensed products</li>\r\n\t\t\t</ul></div><p>&nbsp;</p><p><em>Article citation: Drug Safety Update April 2008; Vol 1, Issue 9: 7</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>Most herbal medicines on the UK market are currently unlicensed products. Standards vary widely, and it is difficult for consumers or healthcare professionals to identify which products are manufactured to acceptable standards with reliable product information. <a href=\"http://www.mhra.gov.uk/Committees/Medicinesadvisorybodies/HerbalMedicinesAdvisoryCommittee/index.htm\">The Herbal Medicines Advisory Committee</a> was set up 2 years ago to advise the MHRA about safety issues related to herbal medicines.</p><p>The MHRA has previously issued warnings about herbal products that contain the toxic ingredient Aristolochicia species, heavy metals, or potent pharmaceutical substances (eg, fenfluramine).</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Safety case studies:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>Recently, <a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON084741\" target=\"_blank\">we warned consumers about a herbal body lotion (OSAS)</a> that claimed to contain natural ingredients, but tested positive for betamethasone. The product was brought to our attention by a paediatric dermatologist who was concerned that a parent of a baby he was treating for eczema had started using the product on the infant</li>\r\n\t\t\t\t<li>Reports of suspected adverse drug reactions were linked to an unlicensed herbal product that was marketed for diabetes, which gave dangerous advice to patients to stop taking prescribed medication</li>\r\n\t\t\t</ul></div><p>For further examples of previous safety warnings about herbal medicines that contain potent or toxic ingredients see <a href=\"http://www.mhra.gov.uk/Howweregulate/Medicines/Herbalmedicines/HerbalSafetyNews/Currentsafetyissues/index.htm\">Herbal Safety News: Current safety issues</a></p><h2>New regulation to safeguard public health</h2><p>Regulation safeguards will be improved by the recent introduction of the Traditional Herbal Registration (THR) scheme. The first products registered in the UK under this scheme are now coming onto the market. As at March 2008, 11 products have been registered covering a total of ten different herbs. Registered products have been assessed by the MHRA and meet systematic standards of safety, quality, and patient information. Registered products are suitable for use without medical supervision, and indications are based on traditional use rather than proven efficacy. Herbal medicines with a Marketing Authorisation also continue to be available.</p><p>See also&#160;<a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON014134\">Press release: Poor practice in the unlicensed herbal sector - MHRA warns the public to be vigilant</a></p><p>The Herbal Medicines Advisory Committee believes it is important to use the growing availability of regulated products and reliable information to enhance patient safety. Healthcare professionals will be increasingly better placed to advise patients who wish to self-medicate with over-the-counter herbal products on how they can make an informed choice in appropriate situations.</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>How to identify regulated herbal products:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>Herbal medicines with a Traditional Herbal Registration have a THR number on the product label</li>\r\n\t\t\t\t<li>Herbal medicines with a Marketing Authorisation have a PL number on the product label</li>\r\n\t\t\t</ul></div><p>The image below shows part of the label, including THR, for Niteherb (valerian, for temporary relief of sleep disturbances due to symptoms of mild anxiety):</p><p><img border=\"0\" src=\"http://www.mhra.gov.uk/idcm2/groups/pl-p/documents/websiteresources/con084893.jpg\"></p><p>The image below shows an extract from the leaflet for Prostasan (saw palmetto, for relief of symptoms of an enlarged prostate), which has a THR:</p><p><img border=\"0\" src=\"http://www.mhra.gov.uk/idcm2/groups/pl-p/documents/websiteresources/con084895.jpg\"></p><div class=\"dull_highlight\">\r\n\t\t\t<strong>Sources of information about herbal medicines on the MHRA&#8217;s website:</strong>\r\n\t\t\t<p>Use the <a href=\"http://www.mhra.gov.uk/SearchHelp/A-Zindex/index.htm\">A&#8211;Z index</a> to find:</p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li><strong>Public assessment reports for herbal medicines</strong>:<br>    Covers products with a THR, and contains full information on registered products (including the Summary of Product Characteristics)</li>\r\n\t\t\t\t<li><strong>Herbal information sheets</strong>:<br>    Aimed at consumers; gives non-product-specific information about safe use of individual herbs; a reference collection of these sheets will progressively be prepared, making use of the MHRA&#8217;s assessment of THR applications</li>\r\n\t\t\t\t<li><strong>Advice to consumers&#8212;safe use of herbal medicines</strong>:<br>    Gives general advice, including avoidance of low-grade unlicensed products</li>\r\n\t\t\t</ul></div><p>&#160;</p><p><em>Article citation: Drug Safety Update April 2008; Vol 1, Issue 9: 7</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2008-04-01", 
  "date_last_modified": "2010-09-17", 
  "_assets": [], 
  "_item_id": 293, 
  "summary": "", 
  "body": "Article date: April 2008\n\nMost herbal medicines on the UK market are currently unlicensed products. Standards vary widely, and it is difficult for consumers or healthcare professionals to identify which products are manufactured to acceptable standards with reliable product information. [The Herbal Medicines Advisory Committee](http://www.mhra.gov.uk/Committees/Medicinesadvisorybodies/HerbalMedicinesAdvisoryCommittee/index.htm) was set up 2 years ago to advise the MHRA about safety issues related to herbal medicines.\n\nThe MHRA has previously issued warnings about herbal products that contain the toxic ingredient Aristolochicia species, heavy metals, or potent pharmaceutical substances (eg, fenfluramine).\n\nSafety case studies:  \n  \n  * Recently, [we warned consumers about a herbal body lotion (OSAS)](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON084741) that claimed to contain natural ingredients, but tested positive for betamethasone. The product was brought to our attention by a paediatric dermatologist who was concerned that a parent of a baby he was treating for eczema had started using the product on the infant  \n  * Reports of suspected adverse drug reactions were linked to an unlicensed herbal product that was marketed for diabetes, which gave dangerous advice to patients to stop taking prescribed medication  \n  \nFor further examples of previous safety warnings about herbal medicines that contain potent or toxic ingredients see [Herbal Safety News: Current safety issues](http://www.mhra.gov.uk/Howweregulate/Medicines/Herbalmedicines/HerbalSafetyNews/Currentsafetyissues/index.htm)\n\n## New regulation to safeguard public health\n\nRegulation safeguards will be improved by the recent introduction of the Traditional Herbal Registration (THR) scheme. The first products registered in the UK under this scheme are now coming onto the market. As at March 2008, 11 products have been registered covering a total of ten different herbs. Registered products have been assessed by the MHRA and meet systematic standards of safety, quality, and patient information. Registered products are suitable for use without medical supervision, and indications are based on traditional use rather than proven efficacy. Herbal medicines with a Marketing Authorisation also continue to be available.\n\nSee also [Press release: Poor practice in the unlicensed herbal sector - MHRA warns the public to be vigilant](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON014134)\n\nThe Herbal Medicines Advisory Committee believes it is important to use the growing availability of regulated products and reliable information to enhance patient safety. Healthcare professionals will be increasingly better placed to advise patients who wish to self-medicate with over-the-counter herbal products on how they can make an informed choice in appropriate situations.\n\nHow to identify regulated herbal products:  \n  \n  * Herbal medicines with a Traditional Herbal Registration have a THR number on the product label  \n  * Herbal medicines with a Marketing Authorisation have a PL number on the product label  \n  \nThe image below shows part of the label, including THR, for Niteherb (valerian, for temporary relief of sleep disturbances due to symptoms of mild anxiety):\n\nThe image below shows an extract from the leaflet for Prostasan (saw palmetto, for relief of symptoms of an enlarged prostate), which has a THR:\n\nSources of information about herbal medicines on the MHRA’s website:\n\nUse the [A–Z index](http://www.mhra.gov.uk/SearchHelp/A-Zindex/index.htm) to find:  \n  \n  * Public assessment reports for herbal medicines:  \nCovers products with a THR, and contains full information on registered products (including the Summary of Product Characteristics)  \n  * Herbal information sheets:  \nAimed at consumers; gives non-product-specific information about safe use of individual herbs; a reference collection of these sheets will progressively be prepared, making use of the MHRA’s assessment of THR applications  \n  * Advice to consumers—safe use of herbal medicines:  \nGives general advice, including avoidance of low-grade unlicensed products  \n  \n \n\nArticle citation: Drug Safety Update April 2008; Vol 1, Issue 9: 7\n"
}